| scholarly article | Q13442814 |
| P2093 | author name string | G M Air | |
| C Liu | |||
| R W Compans | |||
| M C Eichelberger | |||
| P2860 | cites work | Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase | Q40045290 |
| Role of salivary mucins in the protection of the oral cavity. | Q40263636 | ||
| Further studies on the role of neuraminidase and the mechanism of low pH dependence in influenza virus-induced membrane fusion | Q41525481 | ||
| Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. | Q45773361 | ||
| Effects of hexose starvation and the role of sialic acid in influenza virus release | Q45794047 | ||
| Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion | Q45794186 | ||
| Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus | Q45808337 | ||
| Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells | Q67657695 | ||
| The function of the neuraminidase in membrane fusion induced by myxoviruses | Q71457328 | ||
| The gene structure and replication of influenza virus | Q22255660 | ||
| The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides | Q24339477 | ||
| Characterization of temperature sensitive influenza virus mutants defective in neuraminidase | Q27865285 | ||
| Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action | Q27867721 | ||
| Roles of alpha beta and gamma delta T cell subsets in viral immunity | Q35876930 | ||
| Future influenza vaccines and the use of genetic recombinants | Q36551515 | ||
| Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus | Q36654449 | ||
| Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase | Q37129134 | ||
| Effect of Antibody to Neuraminidase on the Maturation and Hemagglutinating Activity of an Influenza A 2 Virus | Q37137038 | ||
| Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells | Q37507086 | ||
| The neuraminidase of influenza virus | Q38211862 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| virology | Q7215 | ||
| P304 | page(s) | 1099-1106 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding | |
| P478 | volume | 69 |
| Q41959544 | "Boom" and "Bust" cycles in virus growth suggest multiple selective forces in influenza a evolution |
| Q41613210 | 'Flu' and structure-based drug design |
| Q37336357 | A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein |
| Q35213210 | A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses. |
| Q35762643 | Adaptation of avian influenza A (H6N1) virus from avian to human receptor-binding preference |
| Q33851279 | Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity |
| Q38288880 | Adjustment of receptor-binding and neuraminidase substrate specificities in avian-human reassortant influenza viruses |
| Q35666012 | Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses |
| Q37123091 | An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs |
| Q27630835 | Analysis of inhibitor binding in influenza virus neuraminidase |
| Q34038950 | Animal virus receptors |
| Q34359863 | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). |
| Q33826335 | Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication. |
| Q40792812 | Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis |
| Q71337286 | Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid |
| Q27863797 | Assembly and budding of influenza virus |
| Q38633113 | Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies |
| Q35880794 | Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells |
| Q34678249 | Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus |
| Q21142689 | Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases |
| Q45902241 | Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. |
| Q34123411 | Avian influenza: our current understanding |
| Q33806746 | Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus |
| Q38192283 | Bat-derived influenza-like viruses H17N10 and H18N11. |
| Q38339097 | Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to alpha2,8-linked sialic acid |
| Q35868046 | CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. |
| Q35882160 | Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. |
| Q47551585 | Cathepsin B plays a key role in optimal production of the influenza A virus |
| Q59351031 | Causes and Consequences of Spatial Within-Host Viral Spread |
| Q33333829 | Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner |
| Q36509477 | Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine |
| Q30395940 | Characterization of antibodies specific for hemagglutinin and neuraminidase proteins of the 1918 and 2009 pandemic H1N1 viruses |
| Q28369317 | Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. |
| Q35857200 | Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en |
| Q33813321 | Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. |
| Q35005209 | Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir |
| Q41877699 | Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity. |
| Q28353147 | Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses |
| Q61811416 | Comprehensive profiling of translation initiation in influenza virus infected cells |
| Q33870586 | Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo |
| Q27678898 | Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6 |
| Q27733696 | Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors |
| Q28349496 | Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities |
| Q37112180 | Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses |
| Q36915506 | Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice |
| Q28370936 | Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping |
| Q44207170 | Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm |
| Q34253013 | Discovery and SAR study of piperidine-based derivatives as novel influenza virus inhibitors |
| Q27316994 | Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance |
| Q30438033 | Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors |
| Q28477244 | Emergence and genetic variation of neuraminidase stalk deletions in avian influenza viruses |
| Q30448118 | Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor |
| Q40092344 | Evolution of Influenza A Virus by Mutation and Re-Assortment |
| Q79782967 | Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005 |
| Q40072156 | Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors. |
| Q46667270 | Fitness cost of reassortment in human influenza. |
| Q38040103 | Function and 3D structure of the N-glycans on glycoproteins |
| Q28379467 | Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140. |
| Q39872758 | Genetic and structural analysis of a virulence determinant in polyomavirus VP1. |
| Q36523991 | Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution |
| Q30360344 | Glycan array analysis of influenza H1N1 binding and release. |
| Q43733762 | Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture |
| Q39271411 | How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example |
| Q33852786 | Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant |
| Q28368172 | Hydrophobic benzoic acids as inhibitors of influenza neuraminidase |
| Q39557208 | Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. |
| Q30152108 | Identification of amino acids in H9N2 influenza virus neuraminidase that are critical for the binding of two mouse monoclonal antibodies |
| Q45743964 | Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice |
| Q36355727 | In silico biology of H1N1: molecular modelling of novel receptors and docking studies of inhibitors to reveal new insight in flu treatment. |
| Q34083704 | In vitro and in vivo assay systems for study of influenza virus inhibitors |
| Q27677074 | Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding |
| Q37220753 | Infectious Pancreatic Necrosis Virus Causing Clinical and Subclinical Infections in Atlantic Salmon Have Different Genetic Fingerprints |
| Q33782736 | Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein |
| Q34601394 | Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility |
| Q33787108 | Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice |
| Q36524947 | Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein |
| Q90241717 | Influenza Hemagglutinin and Neuraminidase: Yin⁻Yang Proteins Coevolving to Thwart Immunity |
| Q61807074 | Influenza Virus Neuraminidase Structure and Functions |
| Q90424861 | Influenza Virus Polymerase Mutation Stabilizes a Foreign Gene Inserted into the Virus Genome by Enhancing the Transcription/Replication Efficiency of the Modified Segment |
| Q34121109 | Influenza hemagglutinin and neuraminidase membrane glycoproteins |
| Q30376236 | Influenza vaccines based on virus-like particles |
| Q45345423 | Influenza virus assembly and budding at the viral budozone. |
| Q33914921 | Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein |
| Q37980627 | Influenza virus entry |
| Q39876368 | Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. |
| Q39593594 | Influenza virus matrix protein is the major driving force in virus budding. |
| Q35873608 | Influenza virus neuraminidase activates latent transforming growth factor beta. |
| Q79340361 | Influenza virus resistance to neuraminidase inhibitors |
| Q33922846 | Influenza virus sialidase: a target for drug discovery. |
| Q30370985 | Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice. |
| Q40947083 | Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein |
| Q44627991 | Inhibition of influenza A virus sialidase activity by sulfatide |
| Q27673446 | Insights into Avian Influenza Virus Pathogenicity: the Hemagglutinin Precursor HA0 of Subtype H16 Has an Alpha-Helix Structure in Its Cleavage Site with Inefficient HA1/HA2 Cleavage |
| Q45422409 | Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5. |
| Q38352631 | Interactions of phage P22 tails with their cellular receptor, Salmonella O-antigen polysaccharide |
| Q38311181 | Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics |
| Q50763875 | Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. |
| Q30386603 | Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses. |
| Q37492366 | Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens |
| Q30352689 | Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus. |
| Q41053445 | Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge |
| Q34529786 | NP body domain and PB2 contribute to increased virulence of H5N1 highly pathogenic avian influenza viruses in chickens |
| Q50289523 | Neuraminidase enzymatic release from sialic acid |
| Q24197463 | Neuraminidase inhibitors for preventing and treating influenza in adults and children |
| Q33990541 | Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? |
| Q38726415 | Neuraminidase-mediated haemagglutination of recent human influenza A(H3N2) viruses is determined by arginine 150 flanking the neuraminidase catalytic site |
| Q33996265 | Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus |
| Q35235777 | Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses |
| Q28379409 | Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection |
| Q41430631 | Oseltamivir expands quasispecies of influenza virus through cell-to-cell transmission |
| Q39759213 | Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations |
| Q26749578 | Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections |
| Q34118992 | Permissive secondary mutations enable the evolution of influenza oseltamivir resistance |
| Q27736884 | Phage P22 tailspike protein: crystal structure of the head-binding domain at 2.3 A, fully refined structure of the endorhamnosidase at 1.56 A resolution, and the molecular basis of O-antigen recognition and cleavage |
| Q33810257 | Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells |
| Q40424441 | Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen |
| Q43640829 | Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice |
| Q38330533 | Probing virus-glycan interactions using glycan microarrays |
| Q44203586 | Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein |
| Q30234943 | Progress of small molecular inhibitors in the development of anti-influenza virus agents |
| Q44466643 | Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents. |
| Q84557620 | Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences |
| Q28344592 | RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza |
| Q30419301 | Recent advances in neuraminidase inhibitor development as anti-influenza drugs |
| Q39875441 | Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids |
| Q35140298 | Role of proteases in the release of porcine epidemic diarrhea virus from infected cells |
| Q34324562 | Role of receptor binding specificity in influenza A virus transmission and pathogenesis |
| Q40815232 | Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding |
| Q34762920 | Selective incorporation of influenza virus RNA segments into virions |
| Q34992653 | Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection |
| Q39601543 | Sialic acid binding activity of transmissible gastroenteritis coronavirus affects sedimentation behavior of virions and solubilized glycoproteins |
| Q30366818 | Strain-specific antiviral activity of iminosugars against human influenza A viruses |
| Q34594957 | Stress-induced reversion to virulence of infectious pancreatic necrosis virus in naïve fry of Atlantic salmon (Salmo salar L.). |
| Q39713974 | Structural and functional analysis of the hemagglutinin-esterase of infectious salmon anaemia virus |
| Q37129248 | Structural glycobiology: a game of snakes and ladders |
| Q30495070 | Structural organization of a filamentous influenza A virus |
| Q27649311 | Structure of the Receptor-Binding Protein of Bacteriophage Det7: a Podoviral Tail Spike in a Myovirus |
| Q44061381 | Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives |
| Q44061376 | Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives |
| Q44061378 | Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir |
| Q45743911 | Synthesis of a polymeric 4-N-linked sialoside which inhibits influenza virus hemagglutinin |
| Q34136179 | Tailspike interactions with lipopolysaccharide effect DNA ejection from phage P22 particles in vitro |
| Q36363199 | The cytoplasmic tail domain of influenza B virus hemagglutinin is important for its incorporation into virions but is not essential for virus replication in cell culture in the presence of compensatory mutations |
| Q35854463 | The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. |
| Q33959377 | The emergence of novel swine influenza viruses in North America |
| Q30397216 | The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients |
| Q39735600 | The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles. |
| Q34677448 | The mechanisms of delayed onset type adverse reactions to oseltamivir |
| Q33483360 | The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus |
| Q36947814 | The universal epitope of influenza A viral neuraminidase fundamentally contributes to enzyme activity and viral replication |
| Q28259304 | The war against influenza: discovery and development of sialidase inhibitors |
| Q34253111 | Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins |
| Q34068037 | Virus maturation by budding |
| Q40623019 | White spot syndrome virus entry is dependent on multiple endocytic routes and strongly facilitated by Cq-GABARAP in a CME-dependent manner |
Search more.